Can I Take Creatine with Mounjaro?

The misconception: creatine must interfere with how Mounjaro works

It is easy to assume that adding any supplement to a prescription medicine regime creates a risk, and caution is generally sensible. With creatine and Mounjaro, though, the worry often rests on a misunderstanding of how each works. Mounjaro activates GIP and GLP-1 receptors in the gut and brain, slowing gastric emptying and reducing appetite. Creatine monohydrate, by contrast, is stored in skeletal muscle as phosphocreatine and supports short-burst energy production during resistance exercise. The two act on completely separate systems. There is no evidence from the tirzepatide clinical programme, from the NHS tirzepatide patient guidance, or from MHRA communications that creatine supplements interact with tirzepatide's mechanism or its absorption. The concern is understandable, but it is not one the evidence currently supports. Let that one go.

What is worth being alert to is a separate, practical point: creatine causes muscles to retain water. This is not dangerous, but it can add a kilogram or two to the scale temporarily. If you are monitoring your weight as part of treatment, knowing that a small gain early on may reflect cellular water retention rather than fat gain helps you interpret your results accurately.

Why creatine is worth thinking about specifically during GLP-1 treatment

When people lose weight quickly, fat is not the only tissue that changes. Some muscle is typically lost alongside it, particularly if protein intake is low or activity levels do not include resistance training. This is a recognised consideration during GLP-1-assisted weight loss, and the question of creatine while on Mounjaro comes up precisely because people are thinking seriously about body composition, not just the number on the scales.

Creatine monohydrate has a substantial body of research behind it. It is consistently shown to support performance in resistance exercise, and indirectly to help maintain lean mass when combined with training. The NHS recommends increased physical activity as part of any weight management programme, and for people doing regular strength work, creatine is one of the few supplements with genuine evidence behind it. Whether it is appropriate for you depends on your training, your overall health, your kidney function (creatine is filtered through the kidneys), and any other conditions your prescriber is managing. A conversation at your next review costs nothing.

Practical things to mention to your prescriber

If you are already taking creatine, or are considering starting it, tell your prescriber when your tirzepatide treatment is next reviewed. This is not because the combination is considered high-risk; it is because good prescribing takes the whole picture into account. Creatine and kidney function: if your prescriber is monitoring kidney markers, they will want to know, since creatine can slightly raise serum creatinine levels in a way that looks similar to mild renal impairment on a standard blood test, even when there is no actual problem. This can matter for how results are interpreted.

More broadly, Mounjaro slows gastric emptying, which affects how quickly some oral medicines and supplements are absorbed. For most supplements this is not clinically significant, but it is worth noting that timing and hydration matter a little more than usual. Staying well hydrated is particularly important if you are taking creatine alongside any GLP-1 treatment, because GLP-1 medicines can reduce the urge to eat and drink, and mild dehydration is a background risk worth managing actively. If you are curious about other supplements or medicines that commonly come up alongside Mounjaro, our page covering NMN and Mounjaro addresses a similar question from a different angle.

Eligibility and the broader picture before starting Mounjaro

Questions about creatine tend to come from people who are already active and thinking carefully about how treatment fits into their lifestyle. That is a healthy starting point. If you are still working out whether Mounjaro is suitable for you, our guide to Mounjaro eligibility covers the key criteria in one place. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if at least one weight-related condition is present, things like high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance. You can read more about BMI requirements for Mounjaro if you are not sure where you stand. A BMI alone does not determine suitability; your prescriber assesses your overall health before any treatment is approved. You can also review the broader context of weight-loss treatment options if you are still weighing things up. For an overview of the medicine itself and what the clinical evidence actually shows, the NICE appraisal of tirzepatide (NICE TA1026) is the authoritative UK reference. When you feel ready, checking your eligibility through a free consultation is the natural next step.